Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV

Rev Med Virol. 2020 Nov;30(6):1-9. doi: 10.1002/rmv.2135. Epub 2020 Jul 30.

Abstract

SARS-CoV-2 virus, a member of the Coronaviridae family, causes Covid-19 pandemic disease with severe respiratory illness. Multiple strategies enable SARS-CoV-2 to eventually overcome antiviral innate immune mechanisms which are important components of viral pathogenesis. This review considers several mechanisms of SARS-CoV-2 innate immune evasion including suppression of IFN-α/β production at the earliest stage of infection, mechanisms that exhaust natural killer cell-mediated cytotoxicity, overstimulation of NLRP3 inflammasome and induction of a cytokine storm. A comparison with SARS-CoV is made. Greater knowledge of these and other immune evasion tactics may provide us with improved possibilities for research into this novel deadly virus.

Keywords: IFN-α/β; NLRP3 inflammasome; SARS-CoV-2; coronaviruses; immune evasion; innate immunity.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • COVID-19 / immunology*
  • COVID-19 / metabolism
  • COVID-19 / virology*
  • Coronavirus / immunology
  • Coronavirus / pathogenicity
  • Coronavirus Infections / immunology
  • Coronavirus Infections / metabolism
  • Coronavirus Infections / virology
  • Disease Susceptibility
  • Host-Pathogen Interactions / immunology*
  • Humans
  • Immune Evasion*
  • Immunity, Innate*
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / pathogenicity
  • Species Specificity
  • Virulence / immunology
  • Virulence Factors / immunology

Substances

  • Biomarkers
  • Virulence Factors